A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosis (Q38650356)

5 September 2017

title

A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

5 September 2017

main subject

0 references

1 reference

1 reference

0 references

3

Soumya Swaminathan

1 reference

5 September 2017

author name string

Ameeruddin Nusrath Unissa

series ordinal

1

1 reference

5 September 2017

Luke Elizabeth Hanna

series ordinal

2

1 reference

5 September 2017

publication date

27 November 2015

1 reference

Chemical Biology and Drug Design

5 September 2017

published in

1 reference

5 September 2017

volume

87

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

537-550

1 reference

In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Molecular mechanisms of drug resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

In vitro antimycobacterial activities of 2'-monosubstituted isonicotinohydrazides and their cyanoborane adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Synthesis, antitubercular activity and pharmacokinetic studies of some schiff bases derived from 1- alkylisatin and isonicotinic acid hydrazide (inh)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

In vitro anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene) isonicotinohydrazide derivatives against isoniazid-resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Drugs in development for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Antimycobacterial activity of a series of pyrazinoic acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Synthesis of pyrazinamide Mannich bases and its antitubercular properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated N-phenylpyrazine-2-carboxamides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

In vitro antimycobacterial activities of pyrazinamide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

New drug candidates and therapeutic targets for tuberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Progress in TB drug development and what is still needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12684

21 January 2018

Identifiers

DOI

10.1111/CBDD.12684

1 reference

5 September 2017

1 reference